Lataa...
CYP46A1-dependent and independent effects of efavirenz treatment
Cholesterol excess in the brain is mainly disposed via cholesterol 24-hydroxylation catalysed by cytochrome P450 46A1, a CNS-specific enzyme. Cytochrome P450 46A1 is emerging as a promising therapeutic target for various brain diseases with both enzyme activation and inhibition having therapeutic po...
Tallennettuna:
| Julkaisussa: | Brain Commun |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7713991/ https://ncbi.nlm.nih.gov/pubmed/33305262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/braincomms/fcaa180 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|